Menu Close

Trending

Pfizer’s Arena buyout looks canny, as etrasimod aces phase 3 trials
NICE finds solution to making Keytruda available for TNBC
Dermavant claims its first approval as FDA clears psoriasis drug
Top 5 takeaways from international hybrid and virtual meeting guidance for pharma
Pfizer makes non-profit pledge for low-income nations

ZS Associates

 
ZS_webinar_holding_slide-approved_13.09.19

Debates & Insight/ Oncology/ Webinars/ Webinars in home page/ Webinars On demand

Cost & Management of Oncology Combination Regimens

, , , , , 0 Comment

Overview Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there

X
Cost & Management of Oncology Combination Regimens
https://pharmaphorum.com/oncology/cost-management-of-oncology-combination-regimens/
 
ZS-Associates-webinar-Image-16x9-Text

Debates/ Debates & Insight/ Market Access/ Webinars/ Webinars in home page/ Webinars On demand

Innovative contracting in Europe – a Trojan horse?

, , , 0 Comment

Overview With pricing of drugs at the centre of political and social debate, the market access and pricing

X
Innovative contracting in Europe – a Trojan horse?
https://pharmaphorum.com/market-access-2/innovative-contracting-in-europe-a-trojan-horse/

Login

CONTINUE TO SITE >
X
Close in 10 seconds